← All publications

NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance Mutations

Drilon A, Horan JC, Tangpeerachaikul A, … Lin JJ · Cancer Discov 2023 · Cancer Discov 13(3):598-615

ROS1 and ROS1 mutants Tyrosine kinase Inhibitor discovery & SARSelectivity & kinome profiling PhosphoSens

Read the paper View on PubMed

More publications on ROS1

Zidesamtinib Selective Targeting of Diverse ROS1 Drug-Resistant Mutations

Tangpeerachaikul A, Mente S, Magrino J, … Pelish HE · Mol Cancer Ther 2025

AssayQuant Technologies logo

 

 

260 Cedar Hill Street
Marlboro MA 01752

Phone: +1 (508) 804-3155

      

© 2026 AssayQuant Technologies, Inc. - All Rights Reserved - Privacy Policy - Terms & Conditions - FCOI